Publications by authors named "Jeffrey Leflein"

Claim this Profile
D
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.
R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, Jeffrey G Leflein, Jonathan M Spergel

Allergy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.
Sayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah, Jeffrey G Leflein, Philippe Bégin

Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Marcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, Gordon Sussman, Michihiro Hide, Jeffrey Leflein

Lancet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.
William E Berger, Jeffrey G Leflein, David E Geller, Bhash Parasuraman, Christopher J Miller

Allergy Asthma Proc· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
Michael Noonan, Jeffrey Leflein, Jonathan Corren, Heribert Staudinger

BMC Pediatr· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Eli O Meltzer, Jon E Stahlman, Jeffrey Leflein, Steven Meltzer, Junghee Lim

Clin Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety features of budesonide inhalation suspension in the long-term treatment of asthma in young children.
Jeffrey G Leflein, James W Baker, Howard Eigen, Ewa Lyzell, Lawrence McDermott

Adv Ther· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
Anders Akerlund, Morgan Andersson, Jeffrey Leflein, Torben Lildholdt, Niels Mygind

J Allergy Clin Immunol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
Jeffrey G Leflein, Stanley J Szefler, Kevin R Murphy, Sherahe Fitzpatrick, Mario Cruz-Rivera

Pediatrics· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis